뇌졸중후우울증의 발병기전 : 생물-심리-사회적 통합 모형 = Pathogenesis of Post-Stroke Depression : A Bio-Psycho-Social Integrative Model

다국어 초록 (Multilingual Abstract)

Depression is common after a stroke and has adverse effects on both the course and prognosis. A proper understanding on the pathogenetic mechanisms of post-stroke depression (PSD) is the first step in the treatment of PSD. PSD should not be considered a purely organic neurological mood syndrome but rather the consequence of a complex interaction model of biological, psychological, and social factors. Based on the pathogenesis, a bio-psycho-social approach is mandatory in the treatment of PSD. A medical team with an integrative bio-psycho-social view should take a pivotal role in the management of PSD.

참고문헌 (Reference)

1 강희주, "뇌졸중후우울증의 유병율 및 예측인자" 대한우울•조울병학회 9 (9): 57-63, 2011

2 Watkins CL, "otivational interviewing early after acute stroke: a randomized, controlled trial" 38 : 1004-1009, 2007

3 Bogousslavsky J, "William Feinberg lecture 2002: emotions, mood, and behavior after stroke" 34 : 1046-1050, 2003

4 Paradiso S, "Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke" 27 : 137-157, 1997

5 Babcock TA, "Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells" 12 : 588-594, 2000

6 Yang L, "The serum interleukin-18 is a potential marker for development of post-stroke depression" 32 : 340-346, 2010

7 Lovejoy EA, "The serotonin transporter intronic VNTR enhancer correlated with a predisposition to affective disorders has distinct regulatory elements within the domain based on the primary DNA sequence of the repeat unit" 17 : 417-420, 2003

8 Morris PL, "The relationship between risk factors for affective disorder and poststroke depression in hospitalised stroke patients" 26 : 208-217, 1992

9 Kendler KS, "The prediction of major depression in women: toward an integrated etiologic model" 150 : 1139-1148, 1993

10 Ormel J, "The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life" 158 : 885-891, 2001

11 Spalletta G, "The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines" 11 : 984-991, 2006

12 Robinson RG, "The clinical neuropsychiatry of stroke. 2nd ed" Cambridge, MA: Cambridge University Press 2006

13 Herrmann N, "The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome" 29 : 618-624, 1998

14 Egan MF, "The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function" 112 : 257-269, 2003

15 Perini F, "Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients" 22 : 289-296, 2001

16 Battersby S, "Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder" 6 : 177-181, 1996

17 Ramasubbu R, "Serotonin transporter gene promoter region polymorphism associated with poststroke major depression" 18 : 96-99, 2006

18 Eriksson M, "Self-reported depression and use of antidepressants after stroke: a national survey" 35 : 936-941, 2004

19 Andersen G, "Risk factors for post-stroke depression" 92 : 193-198, 1995

20 Ouimet MA, "Psychosocial risk factors in poststroke depression: a systematic review" 46 : 819-828, 2001

21 Hackett ML, "Predictors of depression after stroke: a systematic review of observational studies" 36 : 2296-2301, 2005

22 Spalletta G, "Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness" 249 : 1541-1551, 2002

23 Berg A, "Poststroke depression in acute phase after stroke" 12 : 14-20, 2001

24 Robinson RG, "Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke" 12 : 669-680, 1977

25 Allport GW, "Personality: A Psychological interpretation. 1st ed" London: Henry Holt and Company 1937

26 Morris PL, "Personality neuroticism and depression after stroke" 25 : 93-102., 1995

27 Aben I, "Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study" 33 : 2391-2395, 2002

28 Musselman DL, "Paroxetine for the prevention of depression induced by high-dose interferon alfa" 344 : 961-966, 2001

29 Starkstein SE, "Neuropsychiatric aspects of stroke. In Textbook of Geriatric Psychiatry" Washington DC: American Psychiatric Press 457-475, 1994

30 Sharpe M, "Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume" 20 : 815-828, 1990

31 Folstein MF, "Mood disorder as a specific complication of stroke" 40 : 1018-1020, 1977

32 Lipsey JR, "Mood change following bilateral hemisphere brain injury" 143 : 266-273, 1983

33 Aström M, "Major depression in stroke patients. A 3-year longitudinal study" 24 : 976-982, 1993

34 Vila N, "Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke" 34 : 671-675, 2003

35 Bhogal SK, "Lesion location and poststroke depression: systematic review of the methodological limitations in the literature" 35 : 794-802, 2004

36 Morris PL, "Lesion location and poststroke depression" 8 : 399-403, 1996

37 Desmond DW, "Ischemic stroke and depression" 9 : 429-439, 2003

38 Dieguez S, "Is poststroke depression a vascular depression" 226 : 53-58, 2004

39 Hackett ML, "Interventions for Treating Depression After Stroke" 2009

40 Maes M, "Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression" 150 : 1189-1193, 1993

41 Fujikawa T, "Incidence of silent cerebral infarction in patients with major depression" 24 : 1631-1634, 1993

42 Roger VL, "Heart disease and stroke statistics--2011 update: a report from the American Heart Association" 123 : 18-209, 2011

43 Heils A, "Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene" 102 : 247-254, 1995

44 Hackett ML, "Frequency of depression after stroke: a systematic review of observational studies" 36 : 1330-1340, 2005

45 Pohjasvaara T, "Frequency and clinical determinants of poststroke depression" 29 : 2311-2317, 1998

46 Ramasubbu R, "Extended evaluation of serotonin transporter gene functional polymorphisms in subjects with post-stroke depression" 53 : 197-201, 2008

47 Towle D, "Evaluation of social work on depression after stroke" 3 : 89-96, 1989

48 Zhao HW, "Effect of mental intervention on post-stroke depression and rehabilitation of neurological function" 8 : 2408-2409, 2004

49 Angelelli P, "Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study" 110 : 55-63, 2004

50 Gillen R, "Depressive symptoms and history of depression predict rehabilitation efficiency in stroke patients" 82 : 1645-1649, 2001

51 Verdelho A, "Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study" 62 : 905-911, 2004

52 Sharpe M, "Depressive disorders in long-term survivors of stroke. Associations with demographic and social factors, functional status, and brain lesion volume" 164 : 380-386, 1994

53 Pohjasvaara T, "Depression is an independent predictor of poor long-term functional outcome post-stroke" 8 : 315-319, 2001

54 Williams LS, "Depression and other mental health diagnoses increase mortality risk after ischemic stroke" 161 : 1090-1095, 2004

55 MacHale SM, "Depression and its relation to lesion location after stroke" 64 : 371-374, 1998

56 Berg A, "Depression and its assessment among stroke patients and their caregivers" Helsinki: Helsinki univ 2009

57 Dam H, "Depression among patients with stroke" 80 : 118-124, 1989

58 Chau JP, "Depression among Chinese stroke survivors six months after discharge from a rehabilitation hospital" 19 : 3042-3050, 2010

59 Carson AJ, "Depression after stroke and lesion location: a systematic review" 356 : 122-126, 2000

60 Collin SS, "Depression after stroke" 1 : 27-32, 1987

61 Provinciali L, "Depression after first-ever ischemic stroke: the prognostic role of neuroanatomic subtypes in clinical practice" 26 : 592-599, 2008

62 Statistics Korea, "Death statistics"

63 Dantzer R, "Cytokine-induced sickness behavior: mechanisms and implications" 933 : 222-234, 2001

64 Lincoln NB, "Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial" 34 : 111-115, 2003

65 Lieberman D, "Characterization of elderly patients in rehabilitation: stroke versus hip fracture" 21 : 542-547, 1999

66 Williams LS, "Care management of poststroke depression: a randomized, controlled trial" 38 : 998-1003, 2007

67 Kim JM, "BDNF genotype potentially modifying the association between incident stroke and depression" ELSEVIER SCIENCE INC 29 (29): 789-792, 2008

68 Kim JM, "Associations of cytokine gene polymorphisms with post-stroke depression" 2011

69 Kohen R, "Association of serotonin transporter gene polymorphisms with poststroke depression" 65 : 1296-1302, 2008

70 Morris PL, "Association of depression with 10-year poststroke mortality" 150 : 124-129, 1993

71 Olsen TS, "Arm and leg paresis as outcome predictors in stroke rehabilitation" 21 : 247-251, 1990

72 Fedoroff JP, "Are depressive symptoms nonspecific in patients with acute stroke" 148 : 1172-1176, 1991

73 Starkstein SE, "Anosognosia and major depression in 2 patients with cerebrovascular lesions" 40 : 1380-1382, 1990

74 King RB, "Adaptation to stroke: a longitudinal study of depressive symptoms, physical health, and coping process" 9 : 46-66, 2002

75 Parikh RM, "A two year longitudinal study of poststroke mood disorders: prognostic factors related to one and two year outcome" 18 : 45-56, 1988

76 Anguelova M, "A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders" 8 : 574-591, 2003